thehansindia.com
From stomach pain to emotional distress: Understanding IBD in children
IBD in children can affect growth, school life, and emotional health, and early recognition reduces risk of complications. Families should know warning signs and that very early‑onset cases may need genetic evaluation and specialist care.
Parents and caregivers of children with recurrent abdominal symptoms; pediatric patients and teens; pediatricians and pediatric gastroenterologists; newly‑diagnosed families seeking education.
What To Know
This article (a World IBD Day–themed piece) reviews rising pediatric IBD in India, differences between Crohn’s disease and ulcerative colitis, warning signs to watch for, possible causes for increasing incidence, very early‑onset/monogenic IBD, extra‑intestinal manifestations, and the mental‑health impact on children and families.
It emphasizes early recognition, multidisciplinary care, and when genetic testing or referral to tertiary centres may be needed for very young children. The article is an explanatory, patient-facing overview rather than a report of a new study or treatment.
It lists common symptoms (abdominal pain, diarrhoea, bloody stools, weight loss, growth failure) and complications (strictures, fistulae, abscesses, nutritional deficiency), and highlights that some very early‑onset cases may have single‑gene causes and require specialist genetic workup.
It also covers non‑gut effects and mental‑health burdens, and points families toward early evaluation and comprehensive care. If you’re worried about a child: start by noting persistent symptoms listed in the article and discuss them with your paediatrician or a paediatric gastroenterologist.
For infants or very young children with severe or unusual disease, tertiary referral and genetic testing may be discussed. The piece does not give treatment recommendations or new clinical trial data; it’s educational and awareness‑focused.
This is an educational article summarizing current clinical perspectives and public‑health trends rather than reporting new research. It highlights known risk factors and the broader impacts of pediatric IBD; readers should consult clinicians for individualized evaluation and management.
Genetic testing and bone marrow transplant are noted only for specific monogenic cases and are not typical for most pediatric IBD.
